Find Danaparoid sodium manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

API SUPPLIERS

read-more
read-more

01

Aspen API

Netherlands

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAspen API. More than just an API™

Flag Netherlands
Digital Content Digital Content
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Aspen API Comapny Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Undisclosed


Lead Product(s): Danaparoid sodium,Inapplicable

Therapeutic Area: Hematology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Undisclosed

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 18, 2019

Aspen API Comapny Banner

01

Aspen API

Netherlands
arrow

Lead Product(s) : Danaparoid sodium,Inapplicable

Therapeutic Area : Hematology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Undisclosed

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

January 18, 2019

Aspen API Comapny Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAspen API. More than just an API™

Flag Netherlands
Digital Content Digital Content

Regulatory Info :

Registration Country : Sweden

danaparoidnatrium

Brand Name : Orgaran

Dosage Form : INJEKTIONSVÄTSKA, LÖSNING

Dosage Strength : 1250 ANTI-XA E/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Aspen API Comapny Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

read-more
read-more

01

DANAPAROID SODIUM

Brand Name : ORGARAN

Dosage Form : SOLUTION

Dosage Strength : 750UNIT/0.6ML

Packaging : 10X0.6ML AMPS

Approval Date :

Application Number : 2129043

Regulatory Info :

Registration Country : Canada

Aspen API Comapny Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty